(Q36146905)

English

Tumour vascular targeting

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

Tumour vascular targeting (English)

1 reference

Europe PubMed Central

12 August 2017

1

object named as

Dario Neri

1 reference

Europe PubMed Central

12 August 2017

author name string

Roy Bicknell

2

1 reference

Europe PubMed Central

12 August 2017

language of work or name

0 references

publication date

1 June 2005

1 reference

Europe PubMed Central

12 August 2017

Nature Reviews Cancer

1 reference

Europe PubMed Central

12 August 2017

5

1 reference

Europe PubMed Central

12 August 2017

436-446

1 reference

Europe PubMed Central

12 August 2017

6

1 reference

Europe PubMed Central

12 August 2017

https://scigraph.springernature.com/pub.10.1038/nrc1627

0 references

3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Imaging of angiogenesis: from microscope to clinic

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopy

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

The relationship between regional variations in blood flow and histology in a transplanted rat fibrosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Endothelial-cell proliferation in experimental tumours

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Persistent oxidative stress in cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Vascular attack as a therapeutic strategy for cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

The identification of proliferation and tumour-induced proteins in human endothelial cells: a possible target for tumour therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

In silico cloning of novel endothelial-specific genes

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Magic roundabout is a new member of the roundabout receptor family that is endothelial specific and expressed at sites of active angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

EndoPDI, a novel protein-disulfide isomerase-like protein that is preferentially expressed in endothelial cells acts as a stress survival factor

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Robo4 is a vascular-specific receptor that inhibits endothelial migration

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Identification of endothelial cell genes by combined database mining and microarray analysis.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Cloning and characterization of developmental endothelial locus-1: an embryonic endothelial cell protein that binds the alphavbeta3 integrin receptor

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

In silico data filtering to identify new angiogenesis targets from a large in vitro gene profiling data set.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Gene expression profiling in an in vitro model of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Stanniocalcin 1 Is an Autocrine Modulator of Endothelial Angiogenic Responses to Hepatocyte Growth Factor

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Genes expressed in human tumor endothelium

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Tumor endothelial markers: new targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

The human and mouse repertoire of the adhesion family of G-protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Murine endothelial cell lines as models of tumor endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Molecular cloning and characterization of endosialin, a C-type lectin-like cell surface receptor of tumor endothelium

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Isolation and characterization of the notch ligand delta4.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Human endomucin is an endothelial marker

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Modulation of gene expression by hypoxia in human umbilical cord vein endothelial cells: A transcriptomic and proteomic study

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Molecular characterization of a novel human hybrid-type receptor that binds the alpha2-macroglobulin receptor-associated protein

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Analysis of endoglin expression in normal brain tissue and in cerebral arteriovenous malformations

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

In vivo protein biotinylation for identification of organ-specific antigens accessible from the vasculature

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Gene-trap expression screening to identify endothelial-specific genes

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Differentiation between high- and low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

mRNA expression and protein distribution of the unspliced tenascin-C isoform in prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Expression of the Extra Domain B of Fibronectin, a Marker of Angiogenesis, in Head and Neck Tumors

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Isolation of anti-angiogenesis antibodies from a large combinatorial repertoire by colony filter screening

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Selective targeting of tumour neovasculature by a radiohalogenated human antibody fragment specific for the ED-B domain of fibronectin

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Selective targeting of tumoral vasculature: Comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

NMR structure of the human oncofoetal fibronectin ED-B domain, a specific marker for angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Infrared photodetection for the in vivo localisation of phage-derived antibodies directed against angiogenic markers.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Cytotoxic targeting of F9 teratocarcinoma tumours with anti-ED-B fibronectin scFv antibody modified liposomes

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Tumor-targeting properties of antibody-vascular endothelial growth factor fusion proteins

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Selective targeted delivery of TNFalpha to tumor blood vessels.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Engineering a thermostable human prolyl endopeptidase for antibody-directed enzyme prodrug therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

An antibody-calmodulin fusion protein reveals a functional dependence between macromolecular isoelectric point and tumor targeting performance.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Quantitation of the Tumor-Targeting Properties of Antibody Fragments Conjugated to Cell-Permeating HIV-1 TAT Peptides

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Identification of a glioblastoma-associated tenascin-C isoform by a high affinity recombinant antibody

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

131I radioconjugated antibodies for the locoregional radioimmunotherapy of high-grade malignant glioma--phase I and II study

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Tumor regression by targeted gene delivery to the neovasculature

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Abnormalities of Basement Membrane on Blood Vessels and Endothelial Sprouts in Tumors

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Alpha v integrins as receptors for tumor targeting by circulating ligands.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Angiogenesis in health and disease

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Angiogenesis, lymphangiogenesis, and melanoma metastasis

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Vascular endothelial growth factor: basic science and clinical progress

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Inhibition of tumor growth and metastasis by targeting tumor-associated angiogenesis with antagonists to the receptors of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigen

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Phase I trial of yttrium-90-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Vascular-targeted radioimmunotherapy with the alpha-particle emitter 211At

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Lack of specificity of endoglin expression for tumor blood vessels.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Effective cancer targeting using an anti-tumor tissue vascular endothelium-specific monoclonal antibody (TES-23).

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Tumor targeting properties of monoclonal antibodies with different affinity for target antigen CD44V6 in nude mice bearing head-and-neck cancer xenografts

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13).

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Involvement of phosphatidylinositol 4,5-bisphosphate in phosphatidylserine exposure in platelets: use of a permeant phosphoinositide-binding peptide.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Combinatorial administration of molecules that simultaneously inhibit angiogenesis and invasion leads to increased therapeutic efficacy in mouse models of malignant glioma.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

DNA vaccines suppress tumor growth and metastases by the induction of anti-angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Making antibodies by phage display technology

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Ribosome display: an in vitro method for selection and evolution of antibodies from libraries

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Directed evolution of an anti-carcinoembryonic antigen scFv with a 4-day monovalent dissociation half-time at 37 degrees C.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targeting

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Searching for Peptide Ligands with an Epitope Library

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Peptide and protein display on the surface of filamentous bacteriophage.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports--principles and applications

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Advances in the use of synthetic combinatorial chemistry: mixture-based libraries

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

"Peptabody": a new type of high avidity binding protein

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Increased potency of an erythropoietin peptide mimetic through covalent dimerization

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Inhibition of ghrelin action in vitro and in vivo by an RNA-Spiegelmer

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Discovering high-affinity ligands for proteins: SAR by NMR

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Encoded self-assembling chemical libraries

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

DNA-templated organic synthesis and selection of a library of macrocycles

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Drug discovery by dynamic combinatorial libraries

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Small-molecule inhibitors of protein-protein interactions: progressing towards the dream

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

SpeedScreen: label-free liquid chromatography-mass spectrometry-based high-throughput screening for the discovery of orphan protein ligands

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

31 March 2020

Fibronectin isoform distribution in the mouse. II. Differential distribution of the alternatively spliced EIIIB, EIIIA, and V segments in the adult mouse

1 reference

https://api.crossref.org/works/10.1038%2FNRC1627

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/NRC1627

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36146905&oldid=1978483047"